FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Treatment of Diabetic Macular Edema February 4, 2025 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA)......
Biologic drugs, for example, adalimubab (Humira), that affect the immune system may interfere with the effectiveness ofvaccines. Livevaccines, including attenuatedvaccines, should not be used while patients are being treated with biologics that affect the immune system. Patients should complete all ...
Drug absorption is hampered by the corneal and conjunctival epithelial cells that cover the ocular surface. The existence of the blood–ocular barrier restricts the hydrophilic macromolecules from entering the systemic circulation and also avoids the re-entry of xenobiotics from the systemic circulation ...
Pharmaceutics is one of the major components that are taken into consideration while developing a novel drug as it primarily involves in predicting the perfect amount of dosage that is necessary for an individual to get treated for the specific condition. Track 2: Pharmaceutical Science and Research...
Although some suggest etanercept as a treatment for scleritis, There are 3 cases in the spontaneous reports where this drug was implicated as causing or exacerbating scleritis. Because the disease that these drugs are used to treat can also cause scleritis, at this time a drug-induced effect...
an FDA-approved generic drug: • Is chemically the same • Works just as well in the body • Is as safe and effective • Meets the same standards set by the FDA The main difference between the reference brand drug and the generic equivalent is that the generic often costs much less...
Disease-modifying antirheumatic drugs (DMARDs) are therapeutic agents that modulate or suppress the immune system. From: Translational Autoimmunity, 2022 About this pageSet alert Also in subject areas: Chemistry Medicine and Dentistry Nursing and Health ProfessionsShow moreDiscover other topics ...
Predicting patent litigation outcomes for biosimilars is a complex and multifaceted challenge that requires a deep understanding of legal, scientific, and regulatory factors. As the biosimilar industry continues to grow and evolve, stakeholders must stay informed about emerging trends and leverage advanced...
adrug is recognized as a substance that induces changes in the body and can be used to diagnose, treat, or prevent a medical condition. Every drug, vaccine, or biologic must be approved by the U.S Food & Drug Administration (FDA) before it can be used by the public. However, each dr...
"And interestingly, small molecules are still the most," Mackay said. "That doesn't surprise me either because they're proven agents. They haven't stayed the same. The technology to work on small molecules is just so different from when I started in the industry." ...